Accuray Inc (ARAY)
1.62
+0.08
(+5.19%)
USD |
NASDAQ |
May 03, 16:00
1.63
+0.01
(+0.62%)
After-Hours: 20:00
Accuray Enterprise Value: 262.66M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 262.66M |
May 02, 2024 | 254.72M |
May 01, 2024 | 317.20M |
April 30, 2024 | 313.23M |
April 29, 2024 | 322.16M |
April 26, 2024 | 319.18M |
April 25, 2024 | 318.19M |
April 24, 2024 | 320.17M |
April 23, 2024 | 322.16M |
April 22, 2024 | 317.20M |
April 19, 2024 | 314.22M |
April 18, 2024 | 321.16M |
April 17, 2024 | 319.18M |
April 16, 2024 | 323.15M |
April 15, 2024 | 331.08M |
April 12, 2024 | 328.11M |
April 11, 2024 | 334.06M |
April 10, 2024 | 337.03M |
April 09, 2024 | 341.00M |
April 08, 2024 | 340.01M |
April 05, 2024 | 340.01M |
April 04, 2024 | 341.00M |
April 03, 2024 | 340.01M |
April 02, 2024 | 342.98M |
April 01, 2024 | 341.00M |
Date | Value |
---|---|
March 28, 2024 | 346.95M |
March 27, 2024 | 342.98M |
March 26, 2024 | 337.03M |
March 25, 2024 | 347.94M |
March 22, 2024 | 348.93M |
March 21, 2024 | 353.89M |
March 20, 2024 | 359.84M |
March 19, 2024 | 359.84M |
March 18, 2024 | 356.87M |
March 15, 2024 | 360.83M |
March 14, 2024 | 358.85M |
March 13, 2024 | 367.77M |
March 12, 2024 | 371.74M |
March 11, 2024 | 375.71M |
March 08, 2024 | 389.59M |
March 07, 2024 | 384.63M |
March 06, 2024 | 361.82M |
March 05, 2024 | 350.92M |
March 04, 2024 | 353.89M |
March 01, 2024 | 360.83M |
February 29, 2024 | 359.84M |
February 28, 2024 | 360.83M |
February 27, 2024 | 370.75M |
February 26, 2024 | 366.78M |
February 23, 2024 | 363.81M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
209.57M
Minimum
Mar 24 2020
627.73M
Maximum
Nov 04 2021
384.95M
Average
371.77M
Median
Nov 09 2020
Enterprise Value Benchmarks
Boston Scientific Corp | 115.63B |
Integer Holdings Corp | 4.827B |
ResMed Inc | 32.64B |
Glaukos Corp | 5.375B |
Perspective Therapeutics Inc | 1.055B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -9.621M |
Revenue (Quarterly) | 107.24M |
Total Expenses (Quarterly) | 111.20M |
EPS Diluted (Quarterly) | -0.10 |
Gross Profit Margin (Quarterly) | 33.48% |
Profit Margin (Quarterly) | -8.97% |
Earnings Yield | -9.26% |
Operating Earnings Yield | 0.07% |
Normalized Earnings Yield | -7.839 |